European Union

NFAT1-based Therapeutics for Joint Diseases Patent

The European Patent Office has published patent application EP2026030377A1 concerning NFAT1-based therapeutics for joint diseases. The publication date is March 18, 2026, and the application includes various IPC classifications related to pharmaceutical compositions and viral vectors.

EPO Patent EP2026029509A1: Expression Cassette

The European Patent Office has published patent application EP2026029509A1 concerning an expression cassette comprising a Cyba-derived untranslated region and its use. The publication date is March 18, 2026, and the inventors have not yet filed their designation.

Microorganism Patent for Producing Pantothenic Acid or Tryptophan

The European Patent Office has published a patent (EP2026029587A1) for a microorganism modified with a foreign lipoate metabolic gene. This microorganism is intended for the production of pantothenic acid or tryptophan. The publication date is March 18, 2026.

EPO Publishes Patent Application for Porous Hydrogel Scaffolds

The European Patent Office (EPO) has published a patent application (EP2026030014A1) for porous hydrogel scaffolds created by cryogelation. The publication date is March 18, 2026, and it details potential applications in biotechnology and medical fields. The designation of inventors has not yet been filed.

Degradable Branched Polymers for Biomolecule Delivery Patent

The European Patent Office has published a patent application (EP2026030568A1) for degradable branched polymers intended for biomolecule delivery. The publication date is March 18, 2026, and the inventors have not yet filed their designation.

EPO Patent Application: Modified Bacteria for Reproductive Health

The European Patent Office has published patent application EP2026030562A1 concerning modified bacteria for reproductive health. The publication date is March 18, 2026, and it includes IPC classifications related to biotechnology and pharmaceuticals. The designation of the inventor has not yet been filed.

EPO Patent Bulletin: Glycolysis Inhibitors Boost Neural Stem Cells

The European Patent Office (EPO) has published a patent application detailing the use of glycolysis-inhibiting compounds to enhance neural stem cell function. The application, EP2026030225A1, was published on March 18, 2026, and covers various European designated states.

EPO Patent EP2026030634A2: Sustained Transgene Expression Fusion Polypeptides

The European Patent Office has published patent application EP2026030634A2 concerning sustained transgene expression fusion polypeptides. The application details specific fusion polypeptides and their uses, with inventors not yet designated.

TAQ DNA POLYMERASE MUTANT Patent Publication

The European Patent Office has published patent application EP2026030656A1 concerning a TAQ DNA POLYMERASE MUTANT. The publication date is March 18, 2026. The inventors have not yet filed their designation.

EPO Patent Application EP2026030013A1: Clearing Senescent Cells

The European Patent Office has published patent application EP2026030013A1 concerning a method for clearing senescent cells using natural antibodies. The application was published on March 18, 2026, and lists designated states across Europe.